Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2056 AL 2070

IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport

Boado RJ.

Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476.

Neural Mechanisms of Motor Dysfunction in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Koppelmans V, Silvester B, Duff K.

J Alzheimers Dis Rep. 2022 Jun 22;6(1):307-344. doi: 10.3233/ADR-210065. eCollection 2022.

Deep brain stimulation for Parkinson's Disease: A Review and Future Outlook

Malvea A, Babaei F, Boulay C, Sachs A, Park J.

Biomed Eng Lett. 2022 Apr 19;12(3):303-316. doi: 10.1007/s13534-022-00226-y. eCollection 2022 Aug.

High-density neural recording system design

Lee HS, Eom K, Park M, Ku SB, Lee K, Lee HM.

Biomed Eng Lett. 2022 May 30;12(3):251-261. doi: 10.1007/s13534-022-00233-z. eCollection 2022 Aug.

Risk of Developing Non-Cancerous Central Nervous System Diseases Due to Ionizing Radiation Exposure during Adulthood: Systematic Review and Meta-Analyses

Lopes J, Leuraud K, Klokov D, Durand C, Bernier MO, Baudin C.

Brain Sci. 2022 Jul 26;12(8):984. doi: 10.3390/brainsci12080984.

The Hidden Notes of Redox Balance in Neurodegenerative Diseases

Piccirillo S, Magi S, Preziuso A, Serfilippi T, Cerqueni G, Orciani M, Amoroso S, Lariccia V.

Antioxidants (Basel). 2022 Jul 26;11(8):1456. doi: 10.3390/antiox11081456.

Gene-Based Therapeutics for Parkinson's Disease

Shalaby KE, El-Agnaf OMA.

Biomedicines. 2022 Jul 26;10(8):1790. doi: 10.3390/biomedicines10081790.

Hallmarks of neurodegenerative disease: A systems pharmacology perspective

Bloomingdale P, Karelina T, Ramakrishnan V, Bakshi S, Véronneau-Veilleux F, Moye M, Sekiguchi K, Meno-Tetang G, Mohan A, Maithreye R, Thomas VA, Gibbons F, Cabal A, Bouteiller JM, Geerts H.

CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1399-1429. doi: 10.1002/psp4.12852. Epub 2022 Aug 17.

COVID-19 and olfactory dysfunction: a looming wave of dementia?

Kay LM.

J Neurophysiol. 2022 Aug 1;128(2):436-444. doi: 10.1152/jn.00255.2022. Epub 2022 Jul 27.

Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review

Singer W.

Clin Auton Res. 2022 Aug;32(4):291-297. doi: 10.1007/s10286-022-00882-1. Epub 2022 Jul 27.

Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases

Rahmani B, Ghashghayi E, Zendehdel M, Baghbanzadeh A, Khodadadi M.

Physiol Int. 2022 Jun 6;109(2):135-162. doi: 10.1556/2060.2022.00019. Print 2022 Jun 16.

Online Peer Support for People With Parkinson Disease: Narrative Synthesis Systematic Review

Gerritzen EV, Lee AR, McDermott O, Coulson N, Orrell M.

JMIR Aging. 2022 Jul 27;5(3):e35425. doi: 10.2196/35425.

Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis

Chen SJ, Lin CH.

J Biomed Sci. 2022 Jul 27;29(1):54. doi: 10.1186/s12929-022-00839-6.

A Systematic Survey of Research Trends in Technology Usage for Parkinson's Disease

Deb R, An S, Bhat G, Shill H, Ogras UY.

Sensors (Basel). 2022 Jul 23;22(15):5491. doi: 10.3390/s22155491.

Editorial: Translational imaging in neurodegenerative proteinopathies

Ni R, Sahara N, Ji B.

Front Neurosci. 2022 Jul 11;16:952449. doi: 10.3389/fnins.2022.952449. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias